Treatment of Obese Insulin-Resistant Mice With an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin Sensitivity
Lale Özcan(Columbia University Irving Medical Center), Ira Tabas(Columbia University Irving Medical Center), Donald W. Landry, Brian K. Hubbard(Broad Institute), Tiffany Thomas(Columbia University), Michael H. Serrano‐Wu(Broad Institute), Devram Sampat Ghorpade(Columbia University), Xiaoming Xu(Sichuan University), Serge Cremers(Columbia University), Shi‐Xian Deng(Columbia University), Matthias Gaestel(Medizinische Hochschule Hannover)
Cited by 35
Related Papers
Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis
|Circulation|2007|1.4k
Recent insights into the cellular biology of atherosclerosis
|The Journal of Cell Biology|2015|1k
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
|Nature|2010|940